Are we ready to use aliskiren in children? - Wikidata - wikimedia - TriplyDB

Are we ready to use aliskiren in children?

Are we ready to use aliskiren in children?

http://www.wikidata.org/entity/Q37820390

about

Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.

P2860

Q33756874-F2936AE1-3F4F-4435-B411-0E70BAD33C4E Q38087529-196C4263-4DD0-44E1-A306-7AD4653B9DCC

P2860

Are we ready to use aliskiren in children?

http://www.wikidata.org/entity/Q37820390

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Are we ready to use aliskiren in children?

@en

Are we ready to use aliskiren in children?

@nl

type

label

Are we ready to use aliskiren in children?

@en

Are we ready to use aliskiren in children?

@nl

prefLabel

Are we ready to use aliskiren in children?

@en

Are we ready to use aliskiren in children?

@nl

P1433

Q37820390-1CC64BCF-3BF0-4A6A-84B7-4B15FE8FBE96

P1476

Q37820390-1C53BA55-AC80-48E2-9C67-70543D3293BD

P2093

Q37820390-CAE9D562-F645-480A-8CA0-A53B83524E0B

Q37820390-CD41C634-1C98-4A06-8420-F3FA094A3CB6

P2860

Q37820390-121AC551-CD70-4F9D-8DE5-9A754BB46B12

Q37820390-319AB11A-2C42-4E5C-A78C-A4C4B4B1F076

Q37820390-3965BA58-5A01-4465-828B-55DEB4278DE5

Q37820390-6AB11C6B-03D4-49FA-8FF2-EF51D6B0D35E

Q37820390-73CC8331-AD02-4522-B807-AB35C1F83246

Q37820390-B04AD12C-2128-4829-9563-0C39E05B4910

Q37820390-B9A1BD72-C4A4-4B94-BBE7-FE9B1BF05B2C

Q37820390-BC8B4CEC-BD2D-4355-B827-19D2E2BCE277

Q37820390-CD7FD986-532F-4181-8BBE-B730DE2F8DB3

Q37820390-ED2570B9-6A2F-4E62-8449-FCFB436C9D35

P2888

Q37820390-F30866CE-F75C-4797-B639-05176982E297

P304

Q37820390-55B9EB00-F9CC-49D8-BB02-15A08186B09A

P31

Q37820390-56B459AF-EFA8-4625-B6F4-9EBFCA093485

P356

Q37820390-6984053C-3168-490C-BCC3-73B4700E2CF2

P433

Q37820390-489130A5-93DC-4CCD-BEE4-0AE9CABECF5F

P478

Q37820390-D9F9A811-8242-4BCA-8D1A-C82A9D80747A

P50

Q37820390-F52A8B10-5797-4E0D-9561-D3F331CD99B2

P577

Q37820390-EF4703D0-DD34-45EC-8464-4739B52FB1E2

P5875

Q37820390-27958D23-626D-435B-B359-C91B98D844F2

P698

Q37820390-0CB1D4BB-9CBA-4B9F-8F57-B93ADC320B79

P356

S00467-010-1702-Z

P1433

Pediatric Nephrology

P1476

Are we ready to use aliskiren in children?

@en

P2093

Erin Elizabeth Kelland

http://www.w3.org/2001/XMLSchema#string

Leanne Michelle McAuley

http://www.w3.org/2001/XMLSchema#string

P2860

Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.

ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.

Aldosterone blockade in chronic kidney disease: can it improve outcome?

New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulness of the direct renin inhibitor aliskiren.

Strict blood-pressure control and progression of renal failure in children.

Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.

Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

P2888

s00467-010-1702-z

P304

473-477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-010-1702-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49679172

http://www.w3.org/2001/XMLSchema#string

P698

21153557

http://www.w3.org/2001/XMLSchema#string